Skip to main content

Your search for “Therapy Target” returned 457 results

The Key (Proteins) to Self-Renewing Skin

July 5, 2012

In the July 6 issue of Cell Stem Cell, researchers at the University of California, San Diego School of Medicine describe how human epidermal progenitor cells and stem cells control transcription factors to avoid premature differentiation, preserving their ability to produce new skin cells throughout life.

Enzymes Believed to Promote Cancer Actually Suppress Tumors

January 22, 2015

Upending decades-old dogma, a team of scientists at the University of California, San Diego School of Medicine say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.

How Changes in Length of Day Change the Brain and Subsequent Behavior

September 2, 2022

Using a mouse model, UC San Diego researchers describe a process in which affected neurons switch expression of neurotransmitters in response to day length stimuli, triggering related behavioral changes.

With $10 Million Gift, Darlene Shiley Builds Upon Her Husband’s Legacy

January 4, 2022

Marking its 30th anniversary and her enduring interest and support, philanthropist Darlene Shiley has given a $10 million gift for the clinical space expansion of the Shiley Eye Institute at UC San Diego Health.

Proof of Pimple: Mouse Model Validates How “Good” and “Bad” Bacteria Affect Acne

March 7, 2019

Researchers at UC San Diego School of Medicine generated a new mouse model that mimics human acne for the first time, and used it to validate the concept of “good” and “bad” acne bacteria and introduce new possibilities for targeted treatments and vaccines.

Genetic Adaptation Keeps Ethiopians Heart-Healthy Despite High Altitudes

August 3, 2015

Ethiopians have lived at high altitudes for thousands of years, providing a natural experiment for studying human adaptations to low oxygen, a condition known as hypoxia. One factor that may enable Ethiopians to tolerate high altitudes and hypoxia is the endothelin receptor type B (EDNRB) gene. Researchers at University of…

Lab-Grown Human Brain Organoids Mimic an Autism Spectrum Disorder, Help Test Treatments

December 8, 2020

UC San Diego researchers used brain organoids to identify two drug candidates that counteract the genetic deficiencies that cause Rett syndrome, a rare form of autism spectrum disorder.

Mutant Protein in Muscle Linked to Neuromuscular Disorder

April 16, 2014

Spinal and bulbar muscular atrophy (SBMA) is a rare inherited neuromuscular disorder characterized by slowly progressive muscle weakness and atrophy. In a new study published in the online issue of Neuron, a team of scientists at the University of California, San Diego School of Medicine say novel mouse studies indicate…

Newly Discovered HIV Genome Modification May Put a Twist on Vaccine and Drug Design

February 22, 2016

Researchers at University of California, San Diego School of Medicine have discovered that HIV infection of human immune cells triggers a massive increase in methylation, a chemical modification, to both human and viral RNA, aiding replication of the virus. The study, published February 22, 2016 in Nature Microbiology, identifies a…

Start-up Receives up to $15 M to Develop Nanoparticle Therapy for Sepsis Licensed from UC San Diego

October 21, 2020

San Diego-based Cellics Therapeutics, which was co-founded by UC San Diego nanoengineering Professor Liangfang Zhang, has received an award of up to $15M to develop a macrophage cellular nanosponge—nanoparticles cloaked in the cell membranes of macrophages—designed to treat sepsis.

Category navigation with Social links